About Algorithme Pharma
Algorithme Pharma is a Healthcare company based in Montreal (Canada) founded in 1992, and was acquired by Kilmer Group in October 2007. Early-stage CRO services are offered across the US and Canada. Algorithme Pharma offers products and services including Preclinical Services, Clinical Services, Bioanalysis Services, and Manufacturing Services. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Early Stage.
Company details
Algorithme Pharma is an early stage full-service CRO offering its services to the pharmaceutical, biotechnology and generic drug industries. They are part of Altasciences, an early stage North American CRO and have operations both in Canada and the US. The company claims to have conducted over 5500 trials since its inception in 1992. Their clinical trial services portfolio includes large and small molecule bioanalysis, data management, biostatistics, regulatory support, clinical pharmacology and project management. Founded by pharmacology researchers from the University of Montreal, the company annually conducts over 200 Phase IIIa, Bioequivalence and Bioanalysis (preclinical to Phase I-IV) trials. They claim to have access to a patient database with 120000 patients, out of which 40,000 are active. They conduct clinical trials for clients who are all over the world. The company had entered into a partnership with Kilmer Capital Partners, a Canadian investment group in 2007.
- Headquarters Montreal, Canada
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website algopharm.com
- Social LinkedIn X Facebook YouTube
- Acquired by Kilmer Group (Oct 2007)
- Investors
- Acquired byKilmer Group
(Oct 2007)
Products & Services of Algorithme Pharma
Algorithme Pharma offers a comprehensive portfolio of products and services, including Preclinical Services, Clinical Services, Bioanalysis Services, and Manufacturing Services.
Conducts safety evaluations for small and large molecules in preclinical stages.
Performs clinical trials from first-in-human to Phase II studies.
Offers bioanalytical testing for preclinical to Phase IV drug development.
Provides formulation development and stability testing for drugs.
Apps and channels of Algorithme Pharma
its YouTube channel Altasciences has 187K subscribers and 30 videos.
Videos from Algorithme Pharma
The most watched videos on Algorithme Pharma's YouTube channel, Altasciences (187K subscribers). Click a video to play it here.
More on Altasciences.
Investors in Algorithme Pharma
Algorithme Pharma has secured backing from 1 investor. Prominent investors backing the company include Kilmer Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A multi-generational platform for business development and investment is provided. | kilmergroup.com | Toronto, Canada |
Investor details for Algorithme Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Algorithme Pharma
2 dated milestones of Algorithme Pharma across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Algorithme Pharma is founded.
- Exit Acquired by Kilmer Group.
Web traffic of Algorithme Pharma
Websites that share an audience with Algorithme Pharma (algopharm.com).
Websites whose visitors overlap most with Algorithme Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ppdi.com | ppdi.com | 100% | #404,899 | β | |
medsourceconsulting.com | medsourceconsulting.com | 98% | β | ||
| altasciences.com | 96% | 113.4K | #339,610 | View details | |
| chemdiv.com | 95% | 20.9K | #1,521,986 | View details | |
biovail-cro.com | biovail-cro.com | 93% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 20 similar websites and full traffic analytics for Algorithme Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Algorithme Pharma
Algorithme Pharma was founded in 1992.
Algorithme Pharma is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Algorithme Pharma is an early stage full-service CRO offering its services to the pharmaceutical, biotechnology and generic drug industries. They are part of Altasciences, an early stage North American CRO and have operations both in Canada and the US. The company claims to have conducted over 5500 trials since its inception in 1992. Their clinical trial services portfolio includes large and small molecule bioanalysis, data management, biostatistics, regulatory support, clinical pharmacology and project management. Founded by pharmacology researchers from the University of Montreal, the company annually conducts over 200 Phase IIIa, Bioequivalence and Bioanalysis (preclinical to Phase I-IV) trials. They claim to have access to a patient database with 120000 patients, out of which 40,000 are active. They conduct clinical trials for clients who are all over the world. The company had entered into a partnership with Kilmer Capital Partners, a Canadian investment group in 2007.
Algorithme Pharma offers Preclinical Services, Clinical Services, Bioanalysis Services, and Manufacturing Services.
Algorithme Pharma has 1 investor. Key investors include Kilmer Group.
Yes. Algorithme Pharma was acquired by Kilmer Group in October 2007.
